Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.990 | 197 | 4 | 1994 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.800 | None | 0.966 | 175 | 13 | 2002 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 66 | 3 | 2007 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.983 | 58 | 0 | 2007 | 2020 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.300 | None | 1.000 | 39 | 0 | 2001 | 2019 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.974 | 38 | 0 | 2003 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.700 | None | 0.963 | 27 | 11 | 1993 | 2019 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 24 | 0 | 1996 | 2019 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 23 | 0 | 2004 | 2020 | ||||||||
|
zinc finger E-box binding homeobox 2 | 0.471 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 2004 | 2019 | ||||||||
|
WNK lysine deficient protein kinase 1 | 0.416 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 20 | 0 | 2006 | 2019 | ||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
disease | 0.200 | None | 0.941 | 17 | 0 | 1994 | 2019 | ||||||||
|
kinesin family member 1B | 0.516 | 0.808 | 1.00 |
|
disease | 0.200 | None | 0.867 | 15 | 2 | 2010 | 2019 | ||||||||
|
insulin like growth factor 2 receptor | 0.518 | 0.731 | 1.00 |
|
disease | 0.700 | None | 1.000 | 15 | 4 | 1995 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 15 | 1 | 2001 | 2017 | ||||||||
|
AT-rich interaction domain 2 | 0.543 | 0.808 | 1.00 |
|
disease | 0.600 | None | 0.923 | 13 | 0 | 2011 | 2018 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.846 | 13 | 0 | 1994 | 2020 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 12 | 1 | 2009 | 2019 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 12 | 0 | 2012 | 2019 | ||||||||
|
metastasis associated 1 | 0.547 | 0.692 | 1.00 |
|
disease | 0.100 | None | 0.833 | 12 | 0 | 2003 | 2018 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.818 | 11 | 0 | 2008 | 2020 | ||||||||
|
bromodomain containing 4 | 0.446 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2006 | 2019 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2005 | 2018 | ||||||||
|
histone deacetylase 6 | 0.465 | 0.846 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2012 | 2019 | ||||||||
|
clathrin heavy chain | 0.558 | 0.769 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2008 | 2019 |